JP2024534116A5 - - Google Patents
Info
- Publication number
- JP2024534116A5 JP2024534116A5 JP2024511969A JP2024511969A JP2024534116A5 JP 2024534116 A5 JP2024534116 A5 JP 2024534116A5 JP 2024511969 A JP2024511969 A JP 2024511969A JP 2024511969 A JP2024511969 A JP 2024511969A JP 2024534116 A5 JP2024534116 A5 JP 2024534116A5
- Authority
- JP
- Japan
- Prior art keywords
- amino acid
- acid sequence
- chain complementarity
- pharmaceutical composition
- specified
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163236953P | 2021-08-25 | 2021-08-25 | |
| US63/236,953 | 2021-08-25 | ||
| PCT/US2022/041395 WO2023028159A1 (en) | 2021-08-25 | 2022-08-24 | Methods of treating cancers associated with immunosuppressive b cells |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024534116A JP2024534116A (ja) | 2024-09-18 |
| JP2024534116A5 true JP2024534116A5 (cg-RX-API-DMAC7.html) | 2025-08-29 |
Family
ID=85322012
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024511969A Pending JP2024534116A (ja) | 2021-08-25 | 2022-08-24 | 免疫抑制性ｂ細胞と関連付けられる癌を処置する方法 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20240392000A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4392062A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2024534116A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20240055016A (cg-RX-API-DMAC7.html) |
| CN (1) | CN118139639A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2022332971A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3229824A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL310941A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2023028159A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20220159989A (ko) | 2020-02-26 | 2022-12-05 | 바이오그래프 55, 인크. | C19 c38 이중특이적 항체 |
| AU2024239150A1 (en) | 2023-03-21 | 2025-10-02 | Biograph 55, Inc. | Cd19/cd38 multispecific antibodies |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP6594855B2 (ja) * | 2013-03-15 | 2019-10-23 | ゼンコア インコーポレイテッド | ヘテロ二量体タンパク質 |
| EA037548B1 (ru) * | 2015-06-24 | 2021-04-12 | Янссен Байотек, Инк. | Иммуномодуляция и лечение солидных опухолей антителами, которые специфически связывают cd38 |
| WO2021173844A1 (en) * | 2020-02-26 | 2021-09-02 | Biograph 55, Inc. | C19 c38 bispecific antibodies |
-
2022
- 2022-08-24 IL IL310941A patent/IL310941A/en unknown
- 2022-08-24 AU AU2022332971A patent/AU2022332971A1/en active Pending
- 2022-08-24 EP EP22862039.9A patent/EP4392062A4/en active Pending
- 2022-08-24 JP JP2024511969A patent/JP2024534116A/ja active Pending
- 2022-08-24 CA CA3229824A patent/CA3229824A1/en active Pending
- 2022-08-24 WO PCT/US2022/041395 patent/WO2023028159A1/en not_active Ceased
- 2022-08-24 KR KR1020247009786A patent/KR20240055016A/ko active Pending
- 2022-08-24 CN CN202280071314.3A patent/CN118139639A/zh active Pending
- 2022-08-24 US US18/685,489 patent/US20240392000A1/en active Pending